Dr Andreas Hottinger graduated from the Lausanne University Medical school in 1995. After a solid experience in internal medicine at the CHUV, he pursues a formation in Neurology at the Inselspital University Hospital in Bern. During his training he is especially interested in brain tumors and obtains a 3-year fellowship in Neuro-oncology at Sloan Kettering Cancer Center in New York, USA under the supervision of Profs. Lisa DeAngelis and Jerome Posner. Thereafter he completes his oncology training at the University Hospital in Geneva. In 2011, Andreas Hottinger joins the Departments of Clinical Neurosciences and Oncology of the CHUV and is now the Director of the Brain Tumor Center.
His clinical responsibilities include the management of patient suffering from primary brain tumors and metastases to the brain. Dr Hottinger is also an internationally recognized expert in the management of neurologic complications of cancer and their treatments. He collaborates extensively with the teams of neurosurgery, radiation oncology, neuro-radiology, neuropathology and neurorehabilitation.
Dr Hottinger is the primary investigator of several clinical trials that aim to improve the management and outcome of patients with brain tumors. He collaborates extensively with several international organizations such as the EORTC (European Organization for Research and Treatment against Cancer), ASCO (American Society of Clinical Oncology) and EANO (European Association of Neuroonclogy). He is the past president of the Neuro-Oncology group of the SAKK and the founding secretary of the Swiss Neurooncology Organization. He is a member of the Board of the ANOCEF (Association des Neuro-Oncologues d’Expression Française).